INVA Innoviva, Inc.
$20.83 +0.92%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.92%
YTD
+21.10%
P/E
4.18
P/B
1.27
ROE
30%
Div yield
—
Beta
-0.04
Market cap
$1.5B
RSI (14)
48
Next earnings
Nov 3, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$20.78
Close
$20.83
VWAP (n/a)
—
Day high
$20.97
Day low
$20.62
Volume
680K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Innoviva to Participate in Upcoming Investor Conferences
Yahoo Finance · Sep 2
Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
Yahoo Finance · Aug 11
Innoviva (INVA) Q2 Earnings and Revenues Top Estimates
Yahoo Finance · Aug 6
Is Innoviva (INVA) One of the Best Cheap Small Cap Stocks to Buy Now?
Yahoo Finance · Jul 1
Innoviva Specialty Therapeutics (INVA) Partners With Dr. Reddy’s to Expand XACDURO Access Internationally
Yahoo Finance · Jun 23
Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress
Yahoo Finance · Aug 5
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 5, 2026 View → 8-K Aug 5, 2026 View → 8-K May 18, 2026 View → 10-Q May 6, 2026 View → 8-K May 6, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell INVA. Try it in the Lab to size a position and see the risk.